M&A Deal Summary |
|
|---|---|
| Date | 2018-05-01 |
| Target | Alcaliber |
| Sector | Life Science |
| Buyer(s) | GHO Capital Partners |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2014 |
| PE ASSETS | 6.0B EUR |
| Size | Mega |
| Type | Sector Focused |
GHO Capital Partners is a private investment firm focused on the healthcare sector. The Firm will consider opportunities throughout Europe and seeks well-established, profitable businesses that have the potential to deliver a combination of double-digit top line growth, significant efficiency gains and international expansion. GHO Capital Partners was established in 2014 and is based in London, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 25 |
| Sector: Life Science M&A | 5 of 16 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 2 of 6 |
| Country: Spain M&A | 1 of 1 |
| Year: 2018 M&A | 1 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-07-20 |
CellCarta
Montreal, Quebec, Canada CellCarta is a provider of specialized precision medicine laboratory services to the biopharmaceutical industry. Leveraging its integrated analytical platforms in immunology, histopathology, proteomics and genomics, as well as related specimen collection and logistics services, CellCarta supports the entire drug development cycle, from discovery to late-stage clinical trials. CellCarta was founded in 2000 and is based in Montreal, Quebec. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-07-04 |
Linimed Gruppe
Jena, Germany Linimed Gruppe is a provider of 24/7 intensive care services in Germany. Linimed operates a specialised community care model for patients with severe health problems (neurological and neuromuscular diseases, obstructive respiratory diseases and many others). Linimed Gruppe is based in Jena, Germany. |
Buy | - |
